We use cookies in this website. Read about them in our privacy policy. To disable them, configure your browser properly. If you keep using this website, you are accepting those.

Virological and immunological outcomes of elvitegravir-based regimen in a treatment-naive HIV-2-infected patient.

September 24, 2014 By:

Zheng Y
Lambert C
Arendt V
Seguin-Devaux C.

2014 Sep. AIDS.28(15):2329-31.

Other information